Development of an RNA aptamer as a therapeutic agent for synucleinopathies

51

Development of an RNA aptamer as a therapeutic agent for synucleinopathies

Tags:

Previous Article

Cognitive symptoms in cerebral palsy from remote network

RNA aptamer to treat synucleinopathies

Related Posts

Neuronal autophagy in the control of synapse function

Neuronal autophagy in the control of synapse function

163

Ribosome-directed cancer therapies: the tip of the iceberg?

Ribosome-directed cancer therapies: the tip of the iceb...

140

Periodic ER-plasma membrane junctions support long-range Ca2+ signal integration in dendrites

Periodic ER-plasma membrane junctions support long-rang...

129